ESR1 and breast carcinoma: The results of Bai et al. showed that simvastatin increased miR-140-5p in a dose-dependent manner via activating transcription factor NRF1, which reduced breast cancer (ER+ and ER−) cell proliferation and induced apoptosis [27].